
Aislinn Antrim, Managing Editor

Aislinn Antrim is managing editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and received her master’s in communication and media at Rutgers University in 2023.
Articles by Aislinn Antrim, Managing Editor


PharmStart will address financial barriers and time limitations.

Pharmacists can optimize management of this condition with intravenous iron therapy guidance.

High-cost medications necessary for treatment require close management to ensure patient safety and to adhere to payer-specific requirements.

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Rates of GBS were similar between Arexvy and Abrysvo, at 0.12% and 0.11% of total reported events, respectively.

The medication, glepaglutide, is in development for the treatment of adults with short bowel syndrome with intestinal failure who are dependent on parenteral support.

Vanzacaftor/tezacaftor/deutivacaftor (Alyftek) also received approval for the treatment of cystic fibrosis in people 6 years and older who have at least 1 F508del mutation.

This could be attributed to improved diet and health awareness.

Higher costs of efgartigimod alfa are primarily driven by its status as a newly approved, brand-name therapy without a generic alternative.

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

Results suggest that patients commonly receive more than 5 days of treatment, which could be an opportunity for an antimicrobial stewardship initiative.

The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists’ value within the health care system.

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

Although challenges and obstacles persist, artificial intelligence could help rural and smaller pharmacies close gaps in care.

In hospital and critical care settings, pharmacists can play a significant role in educating other health care providers about treatment options, proper dosing, and more.

By identifying patients at high risk for progressing to severe disease and counseling them on their treatment options, pharmacists empower patients to make informed decisions about their treatment.

The addition of samidorphan can support the antipsychotic efficacy of olanzapine while mitigating associated weight gain.

Muvalaplin inhibits the formation of Lp(a) by blocking the initial interaction between apolipoprotein(a) and apo(b).

Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.

The treatment is a type IA prodrug of dexamethasone that targets CD206+ macrophages.

The encouraging results suggest this low-cost, scalable strategy should be considered for population-level outreach globally to improve flu vaccination rates.

Twice-yearly dosing could significantly improve adherence rates.

Value-based payment models are becoming increasingly common, leading clinicians to find novel ways to engage patients and improve disease control with the goal of reducing morbidity, mortality, and cost.

Within the Veterans Health Administration System, primary care pharmacists are embedded in primary care panels and work alongside primary care physicians and nurses to optimize medication management for patients.

Improving collaboration and communication between all members of the health care team is one way to address these challenges.

This is the first trial that tested the effect of any medication on major heart failure outcomes in patients with HFpEF and obesity, according to investigators.

High fluctuations (in the top 25%) in total cholesterol were associated with a 60% increase in dementia and a 23% increase in cognitive decline.

The system, currently in early development in Japan, could minimize the need for blood tests, blood pressure cuffs, or expensive wearable devices.

The global temperature has risen by an average of 0.11° Fahrenheit per decade since 1850, or about 2 degrees in total.
Latest Updated Articles
- Data Demonstrate Survival Benefit of Sacituzumab Govitecan In Metastatic Triple-Negative Breast Cancer Regardless of HR/HER2 Status
Published: September 22nd 2021 | Updated:
- FDA Approves Nivolumab in Combination with Chemotherapy for Advanced, Metastatic Gastric Cancer
Published: April 16th 2021 | Updated:
- FDA Approves Dihydroergotamine Mesylate Nasal Spray for Acute Migraine Treatment
Published: September 3rd 2021 | Updated:
- Apremilast Shows Statistically Significant Improvements in Genital Psoriasis
Published: January 18th 2022 | Updated:
- Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School
Published: June 26th 2025 | Updated:
- FDA Grants Breakthrough Therapy Designation to Patritumab Deruxtecan for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Published: January 4th 2022 | Updated: